Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for ARVN

Stock Name	Arvinas Inc
Ticker	ARVN(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US04335A1051

Show aggregate ARVN holdings

News associated with ARVN

Arvinas, Inc. (NASDAQ:ARVN) Receives $19.76 Average Price Target from Analysts: Arvinas, Inc. (NASDAQ:ARVN – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twenty-two analysts that are covering the stock, Marketbeat.com reports. Ten analysts have rated the stock with a hold recommendation and twelve have assigned a buy recommendation to the company. The average 1-year price target among analysts that have […] - 2025-08-12 04:40:52
XTX Topco Ltd Buys 51,658 Shares of Arvinas, Inc. (NASDAQ:ARVN): XTX Topco Ltd lifted its stake in shares of Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 194.2% in the 1st quarter, HoldingsChannel.com reports. The fund owned 78,257 shares of the company’s stock after acquiring an additional 51,658 shares during the period. XTX Topco Ltd’s holdings in Arvinas were worth $549,000 as of its most recent […] - 2025-08-07 05:00:51
TD Asset Management Inc Has $716,000 Stock Position in Arvinas, Inc. (NASDAQ:ARVN): TD Asset Management Inc decreased its position in Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 16.7% in the 1st quarter, HoldingsChannel reports. The fund owned 101,926 shares of the company’s stock after selling 20,422 shares during the period. TD Asset Management Inc’s holdings in Arvinas were worth $716,000 as of its most recent filing with […] - 2025-08-05 04:37:17
Arvinas, Inc. (NASDAQ:ARVN) Shares Sold by Bank of New York Mellon Corp: Bank of New York Mellon Corp lessened its stake in Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 2.6% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 171,314 shares of the company’s stock after selling 4,599 shares during the quarter. Bank […] - 2025-08-01 04:56:56
Teacher Retirement System of Texas Sells 1,349 Shares of Arvinas, Inc. (NASDAQ:ARVN): Teacher Retirement System of Texas cut its stake in Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 9.4% during the first quarter, HoldingsChannel reports. The firm owned 12,946 shares of the company’s stock after selling 1,349 shares during the period. Teacher Retirement System of Texas’ holdings in Arvinas were worth $91,000 at the end of the […] - 2025-07-22 04:12:50
Arvinas: CEO John Houston Plans To Retire; Board To Lead Search For CEO Replacement: (RTTNews) - Arvinas (ARVN) announced that John Houston, CEO and President, has informed the Board of his plans to retire from his role as President and CEO following a search for, and the appointment of, the new CEO. The Board has begun a search for a new CEO. Houston will remain - 2025-07-09 08:14:42
Arvinas, Inc. (NASDAQ:ARVN) Shares Sold by Hennion & Walsh Asset Management Inc.: Hennion & Walsh Asset Management Inc. reduced its position in Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 2.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 61,877 shares of the company’s stock after selling 1,600 shares during the period. […] - 2025-06-09 05:32:59
Leerink Partnrs Predicts Arvinas’ Q2 Earnings (NASDAQ:ARVN): Arvinas, Inc. (NASDAQ:ARVN – Free Report) – Leerink Partnrs upped their Q2 2025 EPS estimates for Arvinas in a note issued to investors on Sunday, June 1st. Leerink Partnrs analyst A. Berens now anticipates that the company will post earnings of $0.26 per share for the quarter, up from their previous estimate of $0.15. Leerink […] - 2025-06-06 02:15:41
Leerink Partnrs Downgrades Arvinas (NASDAQ:ARVN) to Hold: Leerink Partnrs lowered shares of Arvinas (NASDAQ:ARVN – Free Report) from a strong-buy rating to a hold rating in a research report released on Sunday morning,Zacks.com reports. Several other equities analysts have also commented on the stock. TD Cowen lowered shares of Arvinas from a “buy” rating to a “hold” rating in a research report […] - 2025-06-04 02:18:48
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stake in Arvinas, Inc. (NASDAQ:ARVN): UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 0.7% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 433,531 shares of the company’s stock after buying an […] - 2025-06-01 06:40:58
Brokerages Set Arvinas, Inc. (NASDAQ:ARVN) PT at $20.92: Arvinas, Inc. (NASDAQ:ARVN – Get Free Report) has been given an average recommendation of “Moderate Buy” by the twenty brokerages that are covering the company, MarketBeat Ratings reports. Eight analysts have rated the stock with a hold recommendation and twelve have issued a buy recommendation on the company. The average 12-month price target among brokers […] - 2025-05-29 02:58:53
ProShare Advisors LLC Buys 5,153 Shares of Arvinas, Inc. (NASDAQ:ARVN): ProShare Advisors LLC boosted its stake in shares of Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 31.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 21,349 shares of the company’s stock after purchasing an additional 5,153 shares during the […] - 2025-05-28 04:54:54
Deutsche Bank AG Lowers Stock Holdings in Arvinas, Inc. (NASDAQ:ARVN): Deutsche Bank AG cut its stake in shares of Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 5.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 217,220 shares of the company’s stock after selling 13,166 shares during the quarter. Deutsche Bank […] - 2025-05-20 05:14:53
Dimensional Fund Advisors LP Buys 186,254 Shares of Arvinas, Inc. (NASDAQ:ARVN): Dimensional Fund Advisors LP raised its position in shares of Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 28.3% during the 4th quarter, HoldingsChannel.com reports. The fund owned 843,430 shares of the company’s stock after acquiring an additional 186,254 shares during the period. Dimensional Fund Advisors LP’s holdings in Arvinas were worth $16,168,000 as of its […] - 2025-05-09 05:04:57
Voya Investment Management LLC Reduces Holdings in Arvinas, Inc. (NASDAQ:ARVN): Voya Investment Management LLC lowered its stake in Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 32.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 39,678 shares of the company’s stock after selling 19,312 shares during the quarter. Voya Investment Management LLC owned approximately […] - 2025-05-08 05:26:53
Arvinas (NASDAQ:ARVN) Given New $9.50 Price Target at Citigroup: Arvinas (NASDAQ:ARVN – Get Free Report) had its target price lowered by stock analysts at Citigroup from $10.00 to $9.50 in a research note issued on Monday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. Citigroup’s price target suggests a potential upside of 36.69% from the company’s previous close. ARVN has been […] - 2025-05-07 03:08:49
Arvinas (NASDAQ:ARVN) Receives “Hold” Rating from Truist Financial: Arvinas (NASDAQ:ARVN – Get Free Report)‘s stock had its “hold” rating restated by investment analysts at Truist Financial in a research report issued to clients and investors on Monday, MarketBeat.com reports. They presently have a $11.00 price target on the stock, down from their previous price target of $21.00. Truist Financial’s price objective would suggest […] - 2025-05-07 03:08:47
Arvinas (NASDAQ:ARVN) Price Target Lowered to $10.00 at BMO Capital Markets: Arvinas (NASDAQ:ARVN – Free Report) had its price objective trimmed by BMO Capital Markets from $20.00 to $10.00 in a report released on Monday,Benzinga reports. The firm currently has an outperform rating on the stock. A number of other equities research analysts have also issued reports on ARVN. Piper Sandler reissued an “overweight” rating and […] - 2025-05-06 02:56:43
Arvinas (NASDAQ:ARVN) Given New $24.00 Price Target at HC Wainwright: Arvinas (NASDAQ:ARVN – Free Report) had its target price trimmed by HC Wainwright from $81.00 to $24.00 in a research report released on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the stock. A number of other brokerages have also commented on ARVN. Barclays lowered their price objective on Arvinas from $32.00 […] - 2025-05-05 04:52:55
Barclays PLC Grows Stake in Arvinas, Inc. (NASDAQ:ARVN): Barclays PLC grew its holdings in Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 43.8% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 175,019 shares of the company’s stock after acquiring an additional 53,320 shares during the period. Barclays PLC’s holdings in Arvinas were worth $3,354,000 at the end of the most recent quarter. […] - 2025-04-29 05:18:56
Arvinas, Inc. (NASDAQ:ARVN) Shares Sold by Federated Hermes Inc.: Federated Hermes Inc. decreased its position in shares of Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 64.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 47,491 shares of the company’s stock after selling 86,719 shares during the […] - 2025-04-16 05:13:03
Wellington Management Group LLP Sells 3,053 Shares of Arvinas, Inc. (NASDAQ:ARVN): Wellington Management Group LLP lowered its position in Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 9.3% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 29,736 shares of the company’s stock after selling 3,053 shares during the quarter. Wellington Management Group LLP’s holdings in Arvinas were worth $570,000 at the end of the most […] - 2025-04-15 04:46:51
Arvinas, Inc. (NASDAQ:ARVN) Shares Purchased by Schroder Investment Management Group: Schroder Investment Management Group grew its stake in shares of Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 144.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 58,052 shares of the company’s stock after buying an additional 34,283 shares during the period. Schroder Investment Management […] - 2025-04-08 05:12:53
Arvinas (NASDAQ:ARVN) Earns Buy Rating from HC Wainwright: HC Wainwright restated their buy rating on shares of Arvinas (NASDAQ:ARVN – Free Report) in a research report report published on Monday morning,Benzinga reports. They currently have a $81.00 price objective on the stock. ARVN has been the topic of several other reports. The Goldman Sachs Group cut Arvinas from a “buy” rating to a […] - 2025-04-08 02:40:52
Teacher Retirement System of Texas Has $274,000 Stock Position in Arvinas, Inc. (NASDAQ:ARVN): Teacher Retirement System of Texas raised its position in Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 19.0% during the fourth quarter, HoldingsChannel.com reports. The firm owned 14,295 shares of the company’s stock after buying an additional 2,280 shares during the quarter. Teacher Retirement System of Texas’ holdings in Arvinas were worth $274,000 as of its […] - 2025-04-02 04:44:51
Intech Investment Management LLC Has $463,000 Holdings in Arvinas, Inc. (NASDAQ:ARVN): Intech Investment Management LLC raised its position in Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 69.8% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 24,152 shares of the company’s stock after purchasing an additional 9,926 shares during the period. Intech Investment Management LLC’s holdings in Arvinas were […] - 2025-03-25 07:08:51
Arvinas (NASDAQ:ARVN) Price Target Lowered to $12.00 at Morgan Stanley: Arvinas (NASDAQ:ARVN – Free Report) had its price objective reduced by Morgan Stanley from $48.00 to $12.00 in a report issued on Thursday,Benzinga reports. Morgan Stanley currently has an equal weight rating on the stock. A number of other equities analysts have also recently commented on ARVN. Cantor Fitzgerald reiterated an “overweight” rating on shares […] - 2025-03-14 05:48:58
Arvinas (NASDAQ:ARVN) Price Target Lowered to $32.00 at Guggenheim: Arvinas (NASDAQ:ARVN – Free Report) had its price target decreased by Guggenheim from $57.00 to $32.00 in a research report report published on Thursday morning,Benzinga reports. Guggenheim currently has a buy rating on the stock. A number of other equities analysts also recently commented on the company. Wedbush downgraded Arvinas from an “outperform” rating to […] - 2025-03-14 05:48:56
Arvinas (NASDAQ:ARVN) Downgraded by Wedbush to Neutral: Arvinas (NASDAQ:ARVN – Get Free Report) was downgraded by analysts at Wedbush from an “outperform” rating to a “neutral” rating in a report issued on Wednesday, Marketbeat reports. They presently have a $12.00 price objective on the stock, down from their previous price objective of $57.00. Wedbush’s price target would suggest a potential upside of […] - 2025-03-14 04:34:45
Arvinas (NASDAQ:ARVN) Stock Rating Lowered by Oppenheimer: Arvinas (NASDAQ:ARVN – Get Free Report) was downgraded by analysts at Oppenheimer from an “outperform” rating to a “market perform” rating in a research report issued on Tuesday, Marketbeat Ratings reports. Several other brokerages have also recently weighed in on ARVN. HC Wainwright reaffirmed a “buy” rating and issued a $87.00 price objective on shares […] - 2025-03-13 04:22:59

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) ARVN holdings

Date	Number of ARVN Shares Held	Base Market Value of ARVN Shares	Local Market Value of ARVN Shares	Change in ARVN Shares Held	Change in ARVN Base Value	Current Price per ARVN Share Held	Previous Price per ARVN Share Held
2025-12-03 (Wednesday)	49,901	USD 632,246	USD 632,246	0	USD 50,400	USD 12.67	USD 11.66
2025-12-02 (Tuesday)	49,901	USD 581,846	USD 581,846	1,800	USD 13,773	USD 11.66	USD 11.81
2025-12-01 (Monday)	48,101	USD 568,073	USD 568,073	0	USD -37,278	USD 11.81	USD 12.585
2025-11-28 (Friday)	48,101	USD 605,351	USD 605,351	120	USD 9,427	USD 12.585	USD 12.42
2025-11-27 (Thursday)	47,981	USD 595,924	USD 595,924	0	USD 0	USD 12.42	USD 12.42
2025-11-26 (Wednesday)	47,981	USD 595,924	USD 595,924	360	USD 18,757	USD 12.42	USD 12.12
2025-11-25 (Tuesday)	47,621	USD 577,167	USD 577,167	600	USD 23,730	USD 12.12	USD 11.77
2025-11-24 (Monday)	47,021	USD 553,437	USD 553,437	120	USD 13,137	USD 11.77	USD 11.52
2025-11-21 (Friday)	46,901	USD 540,300	USD 540,300	0	USD 23,451	USD 11.52	USD 11.02
2025-11-20 (Thursday)	46,901	USD 516,849	USD 516,849	-476	USD -29,408	USD 11.02	USD 11.53
2025-11-19 (Wednesday)	47,377	USD 546,257	USD 546,257	119	USD -67,624	USD 11.53	USD 12.99
2025-11-18 (Tuesday)	47,258	USD 613,881	USD 613,881	714	USD 100,035	USD 12.99	USD 11.04
2025-11-17 (Monday)	46,544	USD 513,846	USD 513,846	240	USD 24,413	USD 11.04	USD 10.57

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ARVN by Blackrock for IE00BDZVHG35

Show aggregate share trades of ARVN

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-02 BUY 1,800 11.980 11.660 11.692 USD 21,046 12.83
2025-11-28 BUY 120 12.590 12.295 12.325 USD 1,479 12.84
2025-11-26 BUY 360 12.620 11.780 11.864 USD 4,271 12.84
2025-11-26 BUY 360 12.620 11.780 11.864 USD 4,271 12.84
2025-11-25 BUY 600 12.210 11.593 11.655 USD 6,993 12.84
2025-11-24 BUY 120 11.860 11.530 11.563 USD 1,388 12.85
2025-11-20 SELL -476 11.900 10.980 11.072 USD -5,270 12.87 Profit of 854 on sale
2025-11-19 BUY 119 12.930 10.950 11.148 USD 1,327 12.87
2025-11-18 BUY 714 14.220 11.630 11.889 USD 8,489 12.87
2025-11-17 BUY 240 11.120 10.420 10.490 USD 2,518 12.88
2025-11-14 BUY 120 10.940 10.000 10.094 USD 1,211 12.89
2025-11-12 BUY 119 11.330 10.230 10.340 USD 1,230 12.92
2025-11-10 BUY 119 11.450 10.750 10.820 USD 1,288 12.94
2025-11-06 BUY 119 10.025 9.623 9.664 USD 1,150 12.97
2025-11-04 BUY 120 9.720 9.505 9.527 USD 1,143 13.00
2025-10-30 BUY 600 10.176 9.710 9.757 USD 5,854 13.05
2025-10-29 BUY 240 9.590 9.635 9.631 USD 2,311 13.07
2025-10-22 SELL -476 9.310 9.850 9.796 USD -4,663 13.18 Profit of 1,610 on sale
2025-10-20 BUY 238 9.720 9.820 9.810 USD 2,335 13.22
2025-10-17 BUY 594 9.520 9.680 9.664 USD 5,740 13.24
2025-10-15 BUY 944 9.460 9.560 9.550 USD 9,015 13.26
2025-10-03 BUY 840 9.610 9.780 9.763 USD 8,201 13.31
2025-10-02 BUY 120 9.270 9.370 9.360 USD 1,123 13.33
2025-09-30 BUY 240 8.520 8.710 8.691 USD 2,086 13.38
2025-09-26 BUY 242 8.270 8.430 8.414 USD 2,036 13.45
2025-09-25 BUY 242 7.750 7.880 7.867 USD 1,904 13.48
2025-09-18 BUY 133 7.720 8.110 8.071 USD 1,073 13.52
2025-09-17 BUY 402 7.610 7.880 7.853 USD 3,157 13.55
2025-09-11 SELL -132 7.810 8.080 8.053 USD -1,063 13.62 Profit of 735 on sale
2025-09-10 BUY 264 7.830 8.100 8.073 USD 2,131 13.66
2025-07-17 SELL -260 7.760 7.930 7.913 USD -2,057 13.82 Profit of 1,535 on sale
2025-07-11 SELL -1,048 7.790 7.950 7.934 USD -8,315 13.98 Profit of 6,335 on sale
2025-07-02 BUY 7,205 7.900 8.110 8.089 USD 58,281 14.14
2025-06-25 BUY 262 7.800 7.890 7.881 USD 2,065 14.32
2025-06-20 BUY 3,538 7.440 7.590 7.575 USD 26,800 14.47
2025-06-11 BUY 240 7.670 8.060 8.021 USD 1,925 14.84
2025-06-10 BUY 240 7.820 8.240 8.198 USD 1,968 14.89
2025-06-04 SELL -121 6.950 7.070 7.058 USD -854 15.13 Profit of 976 on sale
2025-04-23 BUY 119 9.070 9.250 9.232 USD 1,099 17.53
2025-04-10 SELL -960 6.620 6.630 6.629 USD -6,364 18.50 Profit of 11,397 on sale
2025-04-08 SELL -120 6.190 6.830 6.766 USD -812 18.78 Profit of 1,441 on sale
2025-04-07 SELL -119 6.370 6.460 6.451 USD -768 18.92 Profit of 1,484 on sale
2025-04-04 SELL -600 6.560 6.800 6.776 USD -4,066 19.07 Profit of 7,375 on sale
2025-04-01 BUY 488 7.030 7.350 7.318 USD 3,571 19.36
2025-03-31 SELL -363 7.020 7.430 7.389 USD -2,682 19.51 Profit of 4,398 on sale
2025-03-21 BUY 2,863 8.750 8.880 8.867 USD 25,386 20.40
2025-03-14 SELL -1,792 8.430 9.020 8.961 USD -16,058 21.23 Profit of 21,982 on sale
2025-03-07 SELL -218 18.280 18.760 18.712 USD -4,079 21.90 Profit of 695 on sale
2025-03-04 SELL -109 16.520 16.870 16.835 USD -1,835 22.12 Profit of 576 on sale
2025-02-25 BUY 220 17.670 17.740 17.733 USD 3,901 22.54
2025-02-19 SELL -109 18.540 19.400 19.314 USD -2,105 22.89 Profit of 390 on sale
2025-02-13 BUY 327 17.670 18.480 18.399 USD 6,016 23.26
2025-02-12 BUY 109 17.950 18.980 18.877 USD 2,058 23.37
2025-02-11 BUY 432 17.680 19.190 19.039 USD 8,225 23.49
2024-12-30 SELL -3,644 19.000 19.170 19.153 USD -69,794 25.84 Profit of 24,359 on sale
2024-11-18 SELL -1,770 23.190 23.320 23.307 USD -41,253 26.89 Profit of 6,339 on sale
2024-11-08 SELL -118 27.140 28.430 28.301 USD -3,340 26.91 Loss of -164 on sale
2024-10-21 SELL -118 25.760 27.300 27.146 USD -3,203 0.00 Loss of -3,203 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-02	BUY	1,800	11.980	11.660	11.692	USD 21,046	12.83
2025-11-28	BUY	120	12.590	12.295	12.325	USD 1,479	12.84
2025-11-26	BUY	360	12.620	11.780	11.864	USD 4,271	12.84
2025-11-26	BUY	360	12.620	11.780	11.864	USD 4,271	12.84
2025-11-25	BUY	600	12.210	11.593	11.655	USD 6,993	12.84
2025-11-24	BUY	120	11.860	11.530	11.563	USD 1,388	12.85
2025-11-20	SELL	-476	11.900	10.980	11.072	USD -5,270	12.87 Profit of 854 on sale
2025-11-19	BUY	119	12.930	10.950	11.148	USD 1,327	12.87
2025-11-18	BUY	714	14.220	11.630	11.889	USD 8,489	12.87
2025-11-17	BUY	240	11.120	10.420	10.490	USD 2,518	12.88
2025-11-14	BUY	120	10.940	10.000	10.094	USD 1,211	12.89
2025-11-12	BUY	119	11.330	10.230	10.340	USD 1,230	12.92
2025-11-10	BUY	119	11.450	10.750	10.820	USD 1,288	12.94
2025-11-06	BUY	119	10.025	9.623	9.664	USD 1,150	12.97
2025-11-04	BUY	120	9.720	9.505	9.527	USD 1,143	13.00
2025-10-30	BUY	600	10.176	9.710	9.757	USD 5,854	13.05
2025-10-29	BUY	240	9.590	9.635	9.631	USD 2,311	13.07
2025-10-22	SELL	-476	9.310	9.850	9.796	USD -4,663	13.18 Profit of 1,610 on sale
2025-10-20	BUY	238	9.720	9.820	9.810	USD 2,335	13.22
2025-10-17	BUY	594	9.520	9.680	9.664	USD 5,740	13.24
2025-10-15	BUY	944	9.460	9.560	9.550	USD 9,015	13.26
2025-10-03	BUY	840	9.610	9.780	9.763	USD 8,201	13.31
2025-10-02	BUY	120	9.270	9.370	9.360	USD 1,123	13.33
2025-09-30	BUY	240	8.520	8.710	8.691	USD 2,086	13.38
2025-09-26	BUY	242	8.270	8.430	8.414	USD 2,036	13.45
2025-09-25	BUY	242	7.750	7.880	7.867	USD 1,904	13.48
2025-09-18	BUY	133	7.720	8.110	8.071	USD 1,073	13.52
2025-09-17	BUY	402	7.610	7.880	7.853	USD 3,157	13.55
2025-09-11	SELL	-132	7.810	8.080	8.053	USD -1,063	13.62 Profit of 735 on sale
2025-09-10	BUY	264	7.830	8.100	8.073	USD 2,131	13.66
2025-07-17	SELL	-260	7.760	7.930	7.913	USD -2,057	13.82 Profit of 1,535 on sale
2025-07-11	SELL	-1,048	7.790	7.950	7.934	USD -8,315	13.98 Profit of 6,335 on sale
2025-07-02	BUY	7,205	7.900	8.110	8.089	USD 58,281	14.14
2025-06-25	BUY	262	7.800	7.890	7.881	USD 2,065	14.32
2025-06-20	BUY	3,538	7.440	7.590	7.575	USD 26,800	14.47
2025-06-11	BUY	240	7.670	8.060	8.021	USD 1,925	14.84
2025-06-10	BUY	240	7.820	8.240	8.198	USD 1,968	14.89
2025-06-04	SELL	-121	6.950	7.070	7.058	USD -854	15.13 Profit of 976 on sale
2025-04-23	BUY	119	9.070	9.250	9.232	USD 1,099	17.53
2025-04-10	SELL	-960	6.620	6.630	6.629	USD -6,364	18.50 Profit of 11,397 on sale
2025-04-08	SELL	-120	6.190	6.830	6.766	USD -812	18.78 Profit of 1,441 on sale
2025-04-07	SELL	-119	6.370	6.460	6.451	USD -768	18.92 Profit of 1,484 on sale
2025-04-04	SELL	-600	6.560	6.800	6.776	USD -4,066	19.07 Profit of 7,375 on sale
2025-04-01	BUY	488	7.030	7.350	7.318	USD 3,571	19.36
2025-03-31	SELL	-363	7.020	7.430	7.389	USD -2,682	19.51 Profit of 4,398 on sale
2025-03-21	BUY	2,863	8.750	8.880	8.867	USD 25,386	20.40
2025-03-14	SELL	-1,792	8.430	9.020	8.961	USD -16,058	21.23 Profit of 21,982 on sale
2025-03-07	SELL	-218	18.280	18.760	18.712	USD -4,079	21.90 Profit of 695 on sale
2025-03-04	SELL	-109	16.520	16.870	16.835	USD -1,835	22.12 Profit of 576 on sale
2025-02-25	BUY	220	17.670	17.740	17.733	USD 3,901	22.54
2025-02-19	SELL	-109	18.540	19.400	19.314	USD -2,105	22.89 Profit of 390 on sale
2025-02-13	BUY	327	17.670	18.480	18.399	USD 6,016	23.26
2025-02-12	BUY	109	17.950	18.980	18.877	USD 2,058	23.37
2025-02-11	BUY	432	17.680	19.190	19.039	USD 8,225	23.49
2024-12-30	SELL	-3,644	19.000	19.170	19.153	USD -69,794	25.84 Profit of 24,359 on sale
2024-11-18	SELL	-1,770	23.190	23.320	23.307	USD -41,253	26.89 Profit of 6,339 on sale
2024-11-08	SELL	-118	27.140	28.430	28.301	USD -3,340	26.91 Loss of -164 on sale
2024-10-21	SELL	-118	25.760	27.300	27.146	USD -3,203	0.00 Loss of -3,203 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ARVN

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	234,233	100	968,006	24.2%
2025-09-18	243,202	0	967,134	25.1%
2025-09-17	115,791	596	437,768	26.5%
2025-09-16	162,763	0	505,813	32.2%
2025-09-15	122,252	1	321,080	38.1%
2025-09-12	216,152	2,100	477,101	45.3%
2025-09-11	297,531	0	697,896	42.6%
2025-09-10	322,473	0	450,083	71.6%
2025-09-09	192,870	0	355,661	54.2%
2025-09-08	358,204	200	796,690	45.0%
2025-09-05	209,706	1,021	690,871	30.4%
2025-09-04	252,398	602	546,727	46.2%
2025-09-03	184,898	0	324,223	57.0%
2025-09-02	151,700	0	305,702	49.6%
2025-08-29	161,168	0	255,248	63.1%
2025-08-28	194,306	0	396,657	49.0%
2025-08-27	279,341	800	853,708	32.7%
2025-08-26	250,695	0	530,493	47.3%
2025-08-25	278,706	156	470,467	59.2%
2025-08-22	170,131	350	500,835	34.0%
2025-08-21	137,435	0	228,397	60.2%
2025-08-20	163,395	0	328,941	49.7%
2025-08-19	167,790	0	575,358	29.2%
2025-08-18	251,440	132	651,999	38.6%
2025-08-15	169,573	307	583,977	29.0%
2025-08-14	178,882	300	412,231	43.4%
2025-08-13	410,428	32	852,729	48.1%
2025-08-12	402,053	23	901,058	44.6%
2025-08-11	399,940	0	1,043,902	38.3%
2025-08-08	393,013	2,910	716,869	54.8%
2025-08-07	463,084	21,705	1,403,171	33.0%
2025-08-06	1,138,751	67,954	2,167,613	52.5%
2025-08-05	283,456	2,709	686,585	41.3%
2025-08-04	158,629	0	331,021	47.9%
2025-08-01	274,787	0	539,650	50.9%
2025-07-31	351,888	775	528,985	66.5%
2025-07-30	487,858	16,908	1,172,143	41.6%
2025-07-29	338,306	5,100	613,333	55.2%
2025-07-28	270,742	693	471,094	57.5%
2025-07-25	204,812	200	458,329	44.7%
2025-07-24	216,396	500	416,568	51.9%
2025-07-23	264,540	5	846,534	31.2%
2025-07-22	245,358	0	537,561	45.6%
2025-07-21	284,000	8,267	704,412	40.3%
2025-07-18	359,341	0	539,548	66.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE